Healthcare Industry News: Brainlab
News Release - December 23, 2013
RaySearch Laboratories: Dutch Clinic Selects RayStation(R)STOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (publ.) (STO:RAYB) has received an order for its RayStation® treatment planning system from Radiotherapy Institute Friesland (RIF) in Leeuwarden, the Netherlands.
RIF is an independent institute that provides radiation therapy to cancer patients in the Dutch province Friesland. The clinic has more than 100 employees and treats about 2000 patients annually with external or internal radiation therapy. RIF strives to maintain the highest level of care by using the latest technologies for radiation therapy and the clinic collaborates closely with other Frisian hospitals and the Dutch radiotherapy community."
At RIF RayStation® will replace the existing treatment planning system and will be used for all radiation treatments from contouring and conventional 3DCRT treatments to more advanced treatments such as IMRT and VMAT. RIF will also have access to RayStation® containing all the latest functionality for research purposes.
“RIF will be large installation for us and one of the leading clinics in the Netherlands so we are naturally very excited about this order. We look forward to working closely with the excellent staff at RIF to help them deliver radiation therapy of the highest quality to the Frisian cancer patients”, says Johan Löf, CEO of RaySearch.”
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,300 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.